Results 151 to 160 of about 166,647 (243)

Activation of autophagy mediated by PI3K/Akt/mTOR signalling cascade alleviates impaired adipose‐derived stem cell osteogenesis in a diabetic microenvironment

British Journal of Pharmacology, EarlyView.
Abstract Background and Purpose Advanced glycation end products (AGEs) contribute to the onset and advancement of diabetic osteoporosis (DOP). Adipose‐derived stem cells (ASCs) have garnered attention in the field of bone renewal; the mechanisms leading to decreased osteogenesis within a diabetic environment are not fully understood.
Fangzhi Lou, Ting Fu, Qilin Li, Pengcheng Rao, Shuanglin Peng, Shi Lu, Tianli Wu, Qing Li, Jingang Xiao   +8 more
wiley   +1 more source

Evaluating the safety and feasibility of allogeneic NK cell infusion in high-risk lymphoma patients post-autologous stem cell transplantation. [PDF]

Discov Oncol
Tavakoli S, Samareh-Salavatipour M, Mardi A, Salehi-Shadkami H, Vaezi M, Barkhordar M, Ahmadvand M.   +6 more
europepmc   +1 more source

Autologous Bone Marrow Transplantation.

Internal Medicine, 1996
openaire   +4 more sources

Experimental Basis and First Application of CLinical Lymphvessel-Transplantation of Secondary Lamphedema [PDF]

, 1981
Baumeister, Rüdiger, Hahn, D., Seifert, J., Wiebecke, B.   +3 more
core  

Temporal trends in relative survival of diffuse large B‐cell lymphoma in Sweden and Denmark in the era of targeted and cellular therapies

British Journal of Haematology, EarlyView.
Sara Harrysson, Sandra Eloranta, Stefanie Antonilli, Mikkel Runason Simonsen, Kristina Sonnevi, Peter Brown, Bjorn E. Wahlin, Per‐Ola Andersson, Judit M. Jørgensen, Mats Jerkeman, Christian B. Poulsen, Gunilla Enblad, Tarec C. El‐Galaly, Karin E. Smedby   +13 more
wiley   +1 more source

PI3Kδ Inhibitor Parsaclisib in Japanese Patients With Relapsed or Refractory Follicular Lymphoma

Cancer Science, EarlyView.
CITADEL‐213 evaluated the efficacy and safety of parsaclisib (PI3Kδ inhibitor) in Japanese patients with relapsed or refractory follicular lymphoma (R/R FL). The objective response rate was 88.1%, with 23.8% of patients experiencing a complete response and 64.3% experiencing a partial response; treatment‐emergent adverse events led to parsaclisib ...
Noriko Fukuhara, Isao Yoshida, Takuro Ishiguro, Katsuya Fujimoto, Junya Kuroda, Toshiki Uchida, Ryusuke Yamamoto, Yoshiaki Ogawa, Yasushi Hiramatsu, Toshiro Ito, Seiichiro Katagiri, Tomonori Nakazato, Kazumi Suzukawa, Kenzo Kinami, Mi Zhou, Eiju Negoro   +15 more
wiley   +1 more source

Injectable Stem Cell-Based Therapies for Myocardial Regeneration: A Review of the Literature. [PDF]

J Funct Biomater
Guo M, Watanabe T, Shinoka T.
europepmc   +1 more source

Regenerating Locus Coeruleus‐Norepinephrine (LC‐NE) Function: A Novel Approach for Neurodegenerative Diseases

Cell Proliferation, EarlyView.
The regeneration of LC‐NE from pluripotent stem cells (PSCs) could significantly mitigate the progression of Neurodegenerative diseases and alleviate associated psychiatric disease symptoms, providing a new approach to the treatment of neurological diseases.
Yana Yang, Yunlong Tao
wiley   +1 more source

Nonselective β-Adrenergic Receptor Inhibitors Impair Hematopoietic Regeneration in Mice and Humans after Hematopoietic Cell Transplants. [PDF]

Cancer Discov
Nishino J, Hu W, Kishtagari A, Shen B, Gao X, Blackman CM, Kassim A, Marneni N, Cherukuri AV, Vittrup R, Kalkan FN, Shah R, Ahn C, Gao A, Ahmedrabie A, Collins RH, Zeidan AM, Bidikian A, Gowda L, Shaffer BC, Madanat YF, Zhao Z, Chung SS, Morrison SJ.   +23 more
europepmc   +1 more source

Hemostatic activation during cardiopulmonary bypass with different aprotinin dosages in pediatric patients having cardiac operations [PDF]

, 1993
Baranky, A., Dietrich, W., Jochum, Marianne, Meisner, H, Mossinger, H., Richter, J. A., Spannagl, Michael, Wendt, P.   +7 more
core